National Institutes of Health
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing January 7, 2028.
Overview
The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT)…